Weight Loss Effects of Glucagon-Like Peptide-One Receptor Analog Treatment in a Severely Obese Patient During Hospital Admission

Obesity is considered an independent risk factor for increased hospital length of stay and can be an obstacle to a safe discharge. Although typically prescribed in the outpatient setting, initiating glucagon-like peptide-one receptor agonists (GLP-1RAs) in the inpatient setting can be efficacious in...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueredo, Yaiseli, Cottone, Claudia, Ferreira, Tanira, Gonzalez, Jesus, Iacobellis, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972903/
https://www.ncbi.nlm.nih.gov/pubmed/36865977
http://dx.doi.org/10.7759/cureus.34331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972903/
https://www.ncbi.nlm.nih.gov/pubmed/36865977
http://dx.doi.org/10.7759/cureus.34331

Ejemplares similares